Science Explorer Interactive view Map
Company · Seattle · United States

Impel Neuropharma (United States)

impelnp.comROR OpenAlex
Research works
43
▲ 1213% vs 2013–17
Citations
957
22.1 per fractional work
Top-10% rate
16.8%
record average 16.5%
Open access
40%
world 28%

Not ranked overall: Impel Neuropharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.84× its world share, 0 worksBiochemistry, Geneti…Neuroscience: 13.26× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 44.38× its world share, 1 worksPharmacology, Toxico…Engineering: 0.15× its world share, 0 worksEngineeringMedicine: 2.80× its world share, 4 worksMedicineDecision Sciences: 2.31× its world share, 0 worksDecision Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 44.4×. Every wedge is a field page.

Which keywords describe research at Impel Neuropharma (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Neurological Disorders, Headache Disorders, Migraine, Quality of Life, COVID-19, Olfactory Dysfunction, Alzheimer's Disease and Pharmacokinetics.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Neurological Disorders7▲ 23×7 topics
  2. Headache Disorders5▲ 434×1 topic
  3. Migraine5▲ 238×1 topic
  4. Quality of Life4▲ 7.1×5 topics
  5. COVID-193▲ 10×1 topic
  6. Olfactory Dysfunction3▲ 152×1 topic
  7. Oxidative Stress3▲ 3.7×7 topics
  8. Alzheimer's Disease2▲ 20×4 topics
  9. Neurodegenerative Diseases2▲ 24×4 topics
  10. Pharmacokinetics2▲ 19×4 topics
  11. Treatment2▲ 3.9×9 topics
  12. Mitochondrial Dysfunction2▲ 13×4 topics
  13. Dendritic Spines2▲ 26×2 topics
  14. Drug Development2▲ 32×2 topics
  15. Pharmacology2▲ 13×4 topics
  16. Genetic Mutations2▲ 8.0×3 topics
  17. Toxicology2▲ 20×3 topics
  18. Brain Development2▲ 19×4 topics
  19. Neuroinflammation2▲ 13×5 topics
  20. Serotonin2▲ 53×2 topics
  21. Chitosan1▲ 57×1 topic
  22. Clinical Trials1▲ 5.2×3 topics
  23. Genetic Variation1▲ 11×3 topics
  24. Stress1▲ 8.3×3 topics
  25. Neural Plasticity1▲ 15×2 topics
  26. Reactive Oxygen Species1▲ 6.0×3 topics
  27. Cell Death1▲ 13×2 topics
  28. Crystal Structure1▲ 11×2 topics
  29. Dopamine1▲ 50×1 topic
  30. Neuroprotection1▲ 7.0×3 topics
  31. Reward Circuitry1▲ 50×1 topic
  32. Aconitum Alkaloids1▲ 122×1 topic
  33. Cell Signaling1▲ 7.6×3 topics
  34. Drug Discovery1▲ 6.6×3 topics
  35. Ischemic Stroke1▲ 20×3 topics
  36. Metabolic Regulation1▲ 9.3×2 topics
  37. Mitochondria1▲ 15×1 topic
  38. Mitochondrial Fusion1▲ 32×1 topic
  39. Synaptic Plasticity1▲ 8.1×3 topics
  40. Traditional Chinese Medicine1▲ 16×1 topic

Which research topics does Impel Neuropharma (United States) publish most on?

By volume in 2022–2025: Migraine and Headache Studies, Advanced Drug Delivery Systems, Olfactory and Sensory Function Studies and Nasal Surgery and Airway Studies.

Migraine and Headache St…2Migraine and Headache Studies: 2 fractional worksAdvanced Drug Delivery S…1Advanced Drug Delivery Systems: 1 fractional worksOlfactory and Sensory Fu…1Olfactory and Sensory Function Studies: 1 fractional worksNasal Surgery and Airway…0Nasal Surgery and Airway Studies: 0 fractional worksDrug Solubulity and Deli…0Drug Solubulity and Delivery Systems: 0 fractional worksTraumatic Brain Injury R…0Traumatic Brain Injury Research: 0 fractional worksNeurological Disorders and Treatments: 0 fractional worksCongenital Ear and Nasal Anomalies: 0 fractional worksNeurological Complications and Syndromes: 0 fractional worksFibromyalgia and Chronic Fatigue Syndrome Research: 0 fractional works
Psychiatry and Mental healthPharmaceutical ScienceSensory SystemsSurgery3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Migraine and Headache Studies Psychiatry and Mental health 2 works
  2. 2 Advanced Drug Delivery Systems Pharmaceutical Science 1 works
  3. 3 Olfactory and Sensory Function Studies Sensory Systems 1 works
  4. 4 Nasal Surgery and Airway Studies Surgery 0 works
  5. 5 Drug Solubulity and Delivery Systems Pharmaceutical Science 0 works
  6. 6 Traumatic Brain Injury Research Epidemiology 0 works
  7. 7 Neurological Disorders and Treatments Neurology 0 works
  8. 8 Congenital Ear and Nasal Anomalies Genetics 0 works
  9. 9 Neurological Complications and Syndromes Psychiatry and Mental health 0 works
  10. 10 Fibromyalgia and Chronic Fatigue Syndrome Research Psychiatry and Mental health 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.0%not open60.0%

World: 28% of research is openly available.

with international co-authors34.2%domestic only65.8%

World: 19% is written across borders.

How has Impel Neuropharma (United States)'s research output changed?

Output in 2018–2022 was 1213% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seattle

All research institutions in Seattle

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.